Gold and Silver Extend Losses After Historic Plunge, Testing Safe-Haven Narrative
Precious metals continue their sharp retreat from January's record highs, with silver leading the decline as market sentiment shifts following key U.S. policy signals.
Precious metals continue their sharp retreat from January's record highs, with silver leading the decline as market sentiment shifts following key U.S. policy signals.
The Singapore-listed food company has turned profitable after years of losses, with a 12% return on capital employed and a significant expansion in its capital base—key indicators watched by investors seeking compounding growth stocks.
As the pet care market expands, investors weigh the focused approach of Chewy against Walmart's diversified scale. While Chewy offers pure exposure, Walmart's broader ecosystem and advertising growth present a compelling alternative.
Shares of SBA Communications have faced persistent pressure, declining over 5% in the past year. A detailed analysis of its discounted cash flow and P/E ratio suggests the wireless infrastructure REIT may be significantly undervalued, presenting a potential entry point for long-term investors.
Cardiac monitoring specialist iRhythm has finalized a significant corporate restructuring, creating a new parent company to serve as its publicly listed entity on Nasdaq. The move is seen as a strategic step to streamline governance and provide operational flexibility as the company expands its AI-driven health platform.
Seagate Technology Holdings' stock surged following a strong fiscal Q2 report, fueled by robust demand from AI and data center markets. The company's revenue guidance and multi-year visibility for its advanced HAMR-based storage platform signal confidence in sustained growth, though execution risks remain.
Travere Therapeutics faces a securities fraud investigation by Robbins Geller Rudman & Dowd LLP, raising questions about the accuracy of its past disclosures. The probe casts a shadow over the company's critical transition, as it banks on its kidney drug FILSPARI to drive growth amid mounting legal and commercial pressures.
Shares of Advantest Corp. have surged nearly 200% in the past year, riding the AI and advanced chipmaking wave. As the stock trades near record highs, investors are grappling with a critical question: has the rally run too far, too fast?
Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.
Shareholder analysis reveals a distinctive ownership structure at Swiss electrical engineering group Burkhalter Holding, where retail investors collectively hold the largest stake, while insiders retain significant control. This balance of power highlights both broad public interest and strong managerial alignment in the CHF1.5 billion company.
Despite an 11% share price decline, Fielmann Group AG's robust Return on Equity and solid financials suggest the market may be overlooking its long-term potential, analysts say.
While investors chase pure-play AI stocks, cybersecurity leader CrowdStrike demonstrates how leveraging AI defensively within a robust platform model can drive sustained, profitable growth amid escalating digital threats.
As Virgin Galactic's stock hovers near historic lows, the market is grappling with a critical question: Is the pioneering space tourism company a deeply undervalued opportunity, or a speculative bet burdened by persistent losses and ambitious, yet unproven, timelines?
Fresenius SE & Co. KGaA (ETR:FRE) faces a challenging period as its stock declines, with a key profitability metric and a high dividend payout strategy raising questions about its near-term growth prospects.
Harrisons Holdings (Malaysia) Berhad's shares have climbed 7.7% in three months. Analysis suggests its above-industry Return on Equity and consistent earnings growth, despite a high dividend payout, may be fueling investor confidence and the recent price momentum.
Amidst a complex global economic backdrop, Asia's equity markets are hiding gems trading significantly below their estimated intrinsic value. We spotlight three companies—from gaming to aviation and medtech—that our cash flow analysis suggests are deeply discounted, offering potential for investors with an eye on long-term fundamentals.
Amidst a backdrop of steady interest rates and cautious global growth, Asian dividend-paying companies offer investors a potential harbor. We examine three firms from across the region balancing yield with operational resilience.
After years of punishing declines, MaxLinear's stock appears deeply discounted. But does a 29% gap between its market price and intrinsic value signal a genuine opportunity, or merely reflect the structural challenges facing the chip designer?
In a landmark deal set to reshape global aluminum supply chains, Aluminum Corporation of China (Chalco) and mining giant Rio Tinto have jointly acquired a controlling interest in Brazil's Companhia Brasileira de Alumínio (CBA). This strategic move marks Chalco's largest overseas investment to date, significantly expanding its international footprint and influence.
Chinese EV maker Li Auto announces a significant organizational overhaul, dissolving its dedicated autonomous driving team to focus resources on 'embodied intelligence' and humanoid robotics, signaling a bold strategic realignment.